Skip to main content

Table 2 Patient characteristics and treatment

From: Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience

Age (yrs) Percent Patients (n = 100)
 < 60 8
 60-69 45
 70-79 43
 ≥ 80 4
Race  
 White 56
 Black 37
 Hispanic 5
 Asian 2
Pre-Tx PSA (ng/ml)  
 ≤ 10 87
 > 10 and ≤ 20 12
 > 20 1
T Stage  
 T1b 1
 T1c 75
 T2a 12
 T2b 8
 T2c 4
Gleason Score  
 2 + 3 = 5 2
 3 + 2 = 5 1
 3 + 3 = 6 42
 3 + 4 = 7 40
 4 + 3 = 7 10
 3 + 5 = 8 1
 4 + 4 = 8 4
Risk Groups  
 Low Risk 37
 Intermediate Risk 55
 High Risk 8
Hormone Treatment  
 Yes 11
 No 89
Dose (Gy)  
 35.00 15
 36.25 85